Cargando…
Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy
Compromised activity is a common impediment for biologics requiring endosome trafficking into target cells. In cancer cells, antibody-drug conjugates (ADCs) are trapped in endosomes or subsequently pumped extracellularly, leading to a reduction in intracellular accumulation. In subsets of dendritic...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227040/ https://www.ncbi.nlm.nih.gov/pubmed/35744930 http://dx.doi.org/10.3390/molecules27123807 |